The Richard Wood Jr. Center for Fetal Diagnosis and Treatment, The Children's Hospital of Philadelphia, Philadelphia, PA.
Department of Neurology and Pediatrics, The Children's Hospital of Philadelphia and the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.
Pediatr Crit Care Med. 2023 May 1;24(5):e224-e235. doi: 10.1097/PCC.0000000000003197. Epub 2023 Feb 22.
We aimed to determine the prevalence of electrographic seizures and associated odds of adverse outcomes of electrographic seizures in neonates with congenital diaphragmatic hernia (CDH) receiving extracorporeal membrane oxygenation (ECMO).
Retrospective, descriptive case series.
Neonatal ICU (NICU) in a quaternary care institution.
All neonates with CDH receiving ECMO undergoing continuous electroencephalographic monitoring (CEEG) and follow-up between January 2012 and December 2019.
None.
All eligible neonates with CDH receiving ECMO underwent CEEG (n = 75). Electrographic seizures occurred in 14 of 75 (19%): they were exclusively electrographic-only in nine of 14, both electrographic-only and electroclinical in three of 14, and electroclinical only in two of 14. Two neonates developed status epilepticus. We identified an association between presence of seizures, rather than not, and longer duration of initial session of CEEG monitoring (55.7 hr [48.2-87.3 hr] vs 48.0 hr [43.0-48.3 hr]; p = 0.001). We also found an association between presence of seizures, rather than not, and greater odds of use of a second CEEG monitoring (12/14 vs 21/61; odds ratio [OR], 11.43 [95% CI, 2.34-55.90; p = 0.0026). Most neonates with seizures (10/14), experienced their onset of seizures more than 96 hours after the start of ECMO. Overall, the presence of electrographic seizures, compared with not, was associated with lower odds of survival to NICU discharge (4/14 vs 49/61; OR 0.10 [95% CI 0.03 to 0.37], p = 0.0006). Also, the presence of seizures-rather than not-was associated with greater odds of a composite of death and all abnormal outcomes on follow-up (13/14 vs 26/61; OR, 17.5; 95% CI, 2.15-142.39; p = 0.0074).
Nearly one in five neonates with CDH receiving ECMO developed seizures during the ECMO course. Seizures were predominantly electrographic-only and when present were associated with great odds of adverse outcomes. The current study provides evidence to support standardized CEEG in this population.
本研究旨在明确体外膜肺氧合(ECMO)治疗先天性膈疝(CDH)新生儿中存在脑电图痫性发作的比例,及其与不良结局的相关性。
回顾性描述性病例系列研究。
一所四级医疗机构的新生儿重症监护病房(NICU)。
2012 年 1 月至 2019 年 12 月间所有接受 ECMO 治疗并进行连续脑电图监测(CEEG)和随访的 CDH 新生儿。
无。
所有纳入的 CDH 新生儿均行 CEEG(n=75)。14 例(19%)存在脑电图痫性发作:其中 9 例为单纯脑电图痫性发作,3 例为脑电图痫性发作合并临床发作,2 例为单纯临床发作。2 例患儿出现癫痫持续状态。我们发现,存在脑电图痫性发作与初始 CEEG 监测时间延长有关(55.7 小时[48.2-87.3 小时] vs 48.0 小时[43.0-48.3 小时];p=0.001),存在脑电图痫性发作与进行第二次 CEEG 监测的可能性更大相关(12/14 例 vs 21/61 例;比值比[OR],11.43[95%置信区间,2.34-55.90];p=0.0026)。大多数(10/14)脑电图痫性发作的患儿在 ECMO 开始后 96 小时以上才出现发作。总体而言,与不存在脑电图痫性发作相比,存在脑电图痫性发作与 NICU 出院时生存率降低相关(4/14 例 vs 49/61 例;OR 0.10[95%置信区间 0.03-0.37],p=0.0006)。此外,存在脑电图痫性发作与随访时死亡和所有异常结局的复合终点发生率增加相关(13/14 例 vs 26/61 例;OR,17.5;95%置信区间,2.15-142.39;p=0.0074)。
将近五分之一接受 ECMO 治疗的 CDH 新生儿在 ECMO 治疗过程中出现痫性发作。痫性发作主要为单纯脑电图痫性发作,存在时不良结局的发生风险较高。本研究为该人群中常规进行 CEEG 监测提供了证据支持。